D Andrew James (Andrew James)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Mass Spectrometry

Binding Protein

Coronavirus Disease

Top Venues

Biotechnology journal

Communications biology

Sanofi Pasteur Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanofi Pasteur Ltd

Canada

Principal Scientist :: Analytical Sciences

Publications

Emily Xiao, Clémentine Mirabel, Didier Clénet, Shaolong Zhu, D Andrew James, Luciano Ettorre, Trevor Williams, Jason Szeto, Nausheen Rahman, Salvador Fernando Ausar
Formulation Development of a COVID-19 Recombinant Spike Protein-Based Vaccine. Vaccines 12 (8) (2024)
Lisa Szymkowicz, Jeffery Gerard, Benjamin Messham, Wai Wan Vivian Tam, D Andrew James
Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines. Toxins 13 (11) (2021)
Shaolong Zhu, Peter Liuni, Tricia Chen, Camille Houy, Derek J Wilson, D Andrew James
Epitope screening using Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS): An accelerated workflow for evaluation of lead monoclonal antibodies. Biotechnology journal (2021)
Salvador F Ausar, Shaolong Zhu, Jessica Duprez, Michael Cohen, Thomas Bertrand, Valérie Steier, Derek J Wilson, Stephen Li, Anthony Sheung, Roger H Brookes, Artur Pedyczak, Alexey Rak, D Andrew James
Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity. Communications biology 3 (1) (2020)